Role of NF-κB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy

Molecular and Cellular Biochemistry

Volumn 366, Issue 1-2, 2012, Pages 287-297

  Rajapurohitam, Venkatesh ^a   Kilic, Ana ^a,b   Javadov, Sabzali ^a,c   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Angiotensin II; Cardiomyocyte hypertrophy; Endothelin 1; Leptin; MAPK; NF B

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN II; CYCLINE; ENDOTHELIN 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANGIOTENSIN II; ANIMALS; CELL ENLARGEMENT; CELL NUCLEUS; CELL SIZE; CELLS, CULTURED; ENDOTHELIN-1; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPERTROPHY; LEPTIN; MYOCYTES, CARDIAC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84862016838     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1307-x     Document Type: Article

References (40)

1. Toth MJ, Gottlieb SS, Fisher ML, Ryan AS, Nicklas BJ, Poehlman ET (1997) Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism 46:450-453 (Pubitemid 27172098)
2. Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ (1998) Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J 19:1547-1551 (Pubitemid 28470477)
3. Moro C, Grauzam S, Ormezzano O, Toufektsian MC, Tanguy S, Calabrese P, Coll JL, Bak I, Juhasz B, Tosaki A, de Leiris J, Boucher F (2011) Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction. J Cell Mol Med 15:1688-1694
4. McGaffin KR, Moravec CS, McTiernan CF (2009) Leptin signaling in the failing and mechanically unloaded human heart. Circ Heart Fail 2:676-683
5. Purdham DM, Rajapurohitam V, Zeidan A, Huang C, Gross GJ, Karmazyn M (2008) A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the post-infarcted rat heart. Am J Physiol Heart Circ Physiol 295:H441-H446
6. Pedersen EB, Danielsen H, Jensen T, Madsen M, Sorensen SS, Thomsen OO (1986) Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure. Eur J Clin Invest 16:56-60 (Pubitemid 16125816)
7. Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, Shigemasa C (2003) Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. J Card Fail 9:318-324 (Pubitemid 37048025)
8. Rajapurohitam V, Javadov S, Purdham DM, Kirshenbaum LA, Karmazyn M (2006) An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol 41:265-274 (Pubitemid 44080214)
9. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A (2001) Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci USA 98:6668-6673 (Pubitemid 32538274)
10. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, Hori M (2002) Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105:509-515 (Pubitemid 34141710)
11. Doi T, Sakoda T, Akagami T, Naka T, Mori Y, Tsujino T, Masuyama T, Ohyanagi M (2008) Aldosterone induces interleukin- 18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes. Am J Physiol Heart Circ Physiol 295:H1279-H1287
12. Sarman B, Skoumal R, Leskinen H, Rysa J, Ilves M, Soini Y, Tuukkanen J, Pikkarainen S, Lako-Futo Z, Papp L, deChatel R, Toth M, Ruskoaho H, Szokodi I (2007) Nuclear factor-kappaB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling. J Hypertens 25:1927-1939 (Pubitemid 47356635)
13. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 375:637-649
14. Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ (2009) Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes. Clin Exp Pharmacol Physiol 36:312-318
15. Xia Y, Karmazyn M (2004) Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulation. J Pharmacol Exp Ther 310:43-51 (Pubitemid 38812693)
16. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M (2003) The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 93:277-279 (Pubitemid 37048239)
17. Gan XT, Chakrabarti S, Karmazyn M (2003) Increased endothelin- 1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation. Can J Physiol Pharmacol 81:105-113 (Pubitemid 36398882)
18. Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, Luo JD (2004) Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 110:1269-1275 (Pubitemid 39202344)
19. Abe Y, Ono K, Kawamura T, Wada H, Kita T, Shimatsu A, Hasegawa K (2007) Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation. Am J Physiol Heart Circ Physiol 292:H2387-H2396 (Pubitemid 47084621)
20. Madani S, De Girolamo S, Munoz DM, Li RK, Sweeney G (2006) Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res 69:716-725 (Pubitemid 43139734)
21. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N (2011) Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol 58:1870-1877
22. Parrinello G, Scaglione R, Pinto A, Corrao S, Cecala M, Di Silvestre G, Amato P, Licata A, Licata G (1996) Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens 9:1186-1191 (Pubitemid 26423642)
23. Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA (2008) Impact of obesity on cardiovascular disease. Endocrinol Metab Clin North Am 37:663-684
24. Van der Heiden K, Cuhlmann S, le Luong A, Zakkar M, Evans (2010) PC Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond) 118:593-605
25. Gutierrez SH, Kuri MR, del Castillo ER (2008) Cardiac role of the transcription factor NF-kappaB. Cardiovasc Hematol Disord 8:153-160
26. Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, El-Jamali A, Dietz R, Scheidereit C, Bergmann MW (2005) Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111:2319-2325 (Pubitemid 40647067)
27. Gupta S, Purcell NH, Lin A, d Sen S (2002) Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 159:1019-1028 (Pubitemid 36055756)
28. Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE, Ertl G, Bauersachs J (2003) Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res 57:749-756 (Pubitemid 36254868)
29. Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A (1998) Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 98:100-103 (Pubitemid 28317888)
30. Kawano S, Kubota T, Monden Y, Tsutsumi T, Inoue T, Kawamura N, Tsutsui H, Sunagawa K (2006) Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 291:H1337-H1344 (Pubitemid 44343679)
31. Brasier AR, Jamaluddin M, Han Y, Patterson C, Runge MS (2000) Angiotensin II induces gene transcription through celltype- dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem 212:155-169
32. Li XC, Zhuo JL (2008) Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens 17:37-43 (Pubitemid 350295195)
33. Celi A, Del Fiorentino A, Cianchetti S, Pedrinelli R (2008) Tissue factor modulation by Angiotensin II: a clue to a better understanding of the cardiovascular effects of renin-angiotensin system blockade? Endocr Metab Immune Disord Drug Targets 8: 308-313
34. Schorlemmer A, Matter ML, Shohet RV (2008) Cardioprotective signaling by endothelin. Trends Cardiovasc Med 18:233-239
35. Zeidan A, Javadov S, Chakrabarti S, Karmazyn M (2008) Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res 77:64-72 (Pubitemid 351195148)
36. Skurk T, van Harmelen V, Blum WF, Hauner H (2005) Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway. Obes Res 13:969-973
37. Chandrasekar B, Valente AJ, Freeman GL, Mahimainathan L, Mummidi S (2006) Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation. Biochem Biophys Res Commun 339:956-963 (Pubitemid 41772904)
38. Perez DM, Papay RS, Shi T (2009) a1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Mol Pharmacol 76:144-152
39. Bkaily G, Avedanian L, Jacques D (2009) Nuclear membrane receptors and channels as targets for drug development in cardiovascular diseases. Can J Physiol Pharmacol 87:108-119
40. Bkaily G, Avedanian L, Al-Khoury J, Provost C, Nader M, D'Orleans-Juste P, Jacques D (2011) Nuclear membrane receptors for ET-1 in cardiovascular function. Am J Physiol Regul Integr Comp Physiol 300:R251-R263